Schizophrenia gene networks and pathways and their applications for novel candidate gene selection

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Sun, Jingchun ^a   Jia, Peilin ^a   Fanous, Ayman H ^b,c   van Den Oord, Edwin ^d   Chen, Xiangning ^c,d   Riley, Brien P ^c,d   Amdur, Richard L ^b   Kendler, Kenneth S ^c,d   Zhao, Zhongming ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACUTE PHASE PROTEIN; AMPA RECEPTOR; AROMATIC HYDROCARBON RECEPTOR; CYCLIC AMP; DOPAMINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FARNESOID X RECEPTOR; FC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUTAMATE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; LIVER X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN KINASE C; RETINOID X RECEPTOR; SEROTONIN RECEPTOR;

ARTICLE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SELECTION; HUMAN; IMMUNE SYSTEM; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVOUS SYSTEM DEVELOPMENT; PATHOPHYSIOLOGY; PROTEIN INTERACTION; SCHIZOPHRENIA;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; SCHIZOPHRENIA;

EID: 77955340562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011351     Document Type: Article

References (36)

1. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, et al. (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 64: 19-28.
2. Ng MYM, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, et al. (2009) Metaanalysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 14: 774-785.
3. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
4. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
5. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al. (2009) Common variants conferring risk of schizophrenia. Nature 460: 744-747.
6. Jimenez-Sanchez G, Childs B, Valle D (2001) Human disease genes. Nature 409: 853-855.
7. Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18: 644-652.
8. Lopez-Bigas N, Blencowe BJ, Ouzounis CA (2006) Highly consistent patterns for inherited human diseases at the molecular level. Bioinformatics 22: 269-277.
9. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci USA 104: 8685-8690.
10. Jonsson PF, Bates PA (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22: 2291-2297.
11. Sun J, Jia P, Fanous AH, Webb BT, van den Oord EJ, et al. (2009) A multidimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics 25: 2595-2602.
12. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
13. Yu H, Greenbaum D, Xin Lu H, Zhu X, Gerstein M (2004) Genomic analysis of essentiality within protein networks. Trends Genet 20: 227-231.
14. Zotenko E, Mestre J, O'Leary DP, Przytycka TM (2008) Why do hubs in the yeast protein interaction network tend to be essential: reexamining the connection between the network topology and essentiality. PLoS Comput Biol 4: e1000140.
15. Philip Klein RR (1995) A nearly best-possible approximation algorithm for node-weighted Steiner trees. J Algorithms 19: 104-115.
16. Erdos P, Rényi A (1960) On the evolution of random graphs. Publ Math Inst Hung Acad Sci 5: 17-60.
17. Albert R, Jeong H, Barabasi AL (2000) Error and attack tolerance of complex networks. Nature 406: 378-382.
18. Adamcsek B, Palla G, Farkas IJ, Derenyi I, Vicsek T (2006) CFinder: locating cliques and overlapping modules in biological networks. Bioinformatics 22: 1021-1023.
19. Miyamoto S, LaMantia AS, Duncan GE, Sullivan P, Gilmore JH, et al. (2003) Recent advances in the neurobiology of schizophrenia. Mol Interv 3: 27-39.
20. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
21. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, et al. (2009) The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 14: 18-29.
22. Jones AL, Mowry BJ, Pender MP, Greer JM (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83: 9-17.
23. Chen X, Wang X, Hossain S, O'Neill FA, Walsh D, et al. (2007) Interleukin 3 and schizophrenia: the impact of sex and family history. Mol Psychiatry 12: 273-282.
24. Schwarz MJ, Kronig H, Riedel M, Dehning S, Douhet A, et al. (2006) IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256: 72-76.
25. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83: 841-850.
26. Palha JA, Goodman AB (2006) Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev 51: 61-71.
27. Li Y, Agarwal P, Rajagopalan D (2008) A global pathway crosstalk network. Bioinformatics 24: 1442-1447.
28. Wang Y, Ju W, Liu L, Fam S, D'Souza S, et al. (2004) alpha-Amino-3-hydroxy- 5-methylisoxazole-4-propionic acid subtype glutamate receptor (AMPAR) endocytosis is essential for N-methyl-D-aspartate-induced neuronal apoptosis. J Biol Chem 279: 41267-41270.
29. Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR (2000) Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484: 217-223.
30. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, et al. (2008) Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13: 570-584.
31. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, et al. (2006) Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 78: 315-333.
32. Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, et al. (2008) Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17: 2293-2309.
33. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, et al. (2009) The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115: 245-253.
34. Breitkreutz B-J, Stark C, Reguly T, Boucher L, Breitkreutz A, et al. (2008) The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 36: D637-640.
35. Li MD, Burmeister M (2009) New insights into the genetics of addiction. Nat Rev Genet 10: 225-231.
36. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Statist Soc B 57: 289-300.